Talk
Symposium 1: Visualizing the Brainshuttle™: Pioneering neuroimaging and mechanistic insights of amyloid clearance with trontinemab
Mon, Nov 16, 2026 · 4:50–5:30 PM EST Ballroom - 4th floor, Boston Marriott Copley Place
About this session
Presentations: (1) Trontinemab in Alzheimer's disease – novel pharmacodynamic insights from the ongoing Phase Ib/IIa Brainshuttle™ AD study; (2) Advanced imaging results from the Brainshuttle™ AD study with trontinemab in Alzheimer's disease; (3) Brain delivery and distribution of the novel Brainshuttle™ Aβ-targeting antibody trontinemab in participants with Alzheimer's disease measured with 89Zr positron emission tomography.
Speakers
-
Washington University in St. Louis
Chair
-
F. Hoffmann-La Roche Ltd
Speaker
-
F. Hoffmann-La Roche Ltd
Speaker
-
Amsterdam UMC, Vrije Universiteit
Speaker